Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-12-03 IQV / IQVIA Holdings Inc. 4 DANHAKL JOHN G By LLC P - Purchase I 200.58 1,275
2024-12-01 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -6,224
2024-11-30 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 3.05 -5,194
2024-11-29 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 75.60 -360
2024-11-29 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 75.37 -5,683
2024-11-25 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.68 31,074
2024-11-25 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.75 68,360
2024-11-19 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 32.05 7,500
2024-11-15 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 15.3575 -5,175
2024-11-08 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C G - Gift D -4,500
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F S - Sale D 215.75 -3,371
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F S - Sale D 216.50 -3,250
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F By Wife S - Sale I 216.50 -1,000
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 Barbo William D By Trust G - Gift I -470
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 78.21 -2,256
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 82 -1,424
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P M - Exercise D 72.27 1,424
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P M - Exercise D 68.62 2,256
2024-11-06 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F G - Gift D -4,540
2024-11-05 BIAF / bioAffinity Technologies, Inc. 4 Edwards James Michael A - Award D 100,000
2024-11-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.72 -47,689
2024-11-01 OABI / OmniAb, Inc. 4 Bertozzi Carolyn R M - Exercise D 17,769
2024-11-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 47,689
2024-11-01 OABI / OmniAb, Inc. 4 Love Steven M - Exercise D 13,333
2024-10-28 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.722 -3,000
2024-10-28 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-10-16 LUNA / Luna Innovations Incorporated 4 Phelan William Lawrence A - Award D 150,000
2024-10-14 MXCT / MaxCyte, Inc. 4 Collins Cynthia A - Award D 51,679
2024-10-12 ABSI / Absci Corporation 4 McClain Sean F - Taxes D 4.07 -14,543
2024-10-12 ABSI / Absci Corporation 4 Bedrick Todd F - Taxes D 4.07 -15,606
2024-10-12 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 4.07 -242
2024-10-12 ABSI / Absci Corporation 4 Busch Andreas F - Taxes D 4.07 -3,092
2024-10-02 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.71 -21,607
2024-10-02 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 21,607
2024-10-02 INCY / Incyte Corporation 4 Denton Sheila A. F - Taxes D 67.63 -2,136
2024-10-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.78 -26,082
2024-10-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 26,082
2024-10-01 INCY / Incyte Corporation 4 Heeson Lee A - Award D 26,447
2024-09-30 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 62
2024-09-30 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 71
2024-09-30 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 78
2024-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 496
2024-09-30 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 496
2024-09-30 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 66.10 378
2024-09-30 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 66.10 368
2024-09-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.820 -3,000
2024-09-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-09-16 MXCT / MaxCyte, Inc. 4 Soleymannezhad Ali A - Award D 10,400
2024-09-13 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 63.37 -382
2024-09-12 INCY / Incyte Corporation 4 Dickinson Jonathan Elliott S - Sale D 62.30 -1,117
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)